Search
Search through the thousands of lawsuits, complaints and recalls on our site.

Winn Dixie Accused of Selling a Bill of Goods to Stockholders

Report Fraud
Case ID: 3173 | Stocks | 11/04/2004

Several class actions have been filed against grocery store operator Winn Dixie Stores, Inc. (NYSE: WIN) and certain of its officers and directors by stockholders who purchased the company's common stock between October 9, 2002, and January 30, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.

The action alleges that throughout the applicable period, Winn-Dixie was suffering from substantial undisclosed long-term business and financial problems. The company was unable to market its Winn-Dixie brand competitively, it was unable to reduce excess expenses when needed, it recorded the carrying value of its long-lived assets at inflated levels, and maintained insufficient reserves for self-insurance. In addition, Winn-Dixie allegedly had no credible or workable marketing plan in place which would allow it to compete effectively with other large supermarket chains and discounters, such as Publix and Costco. Nevertheless, throughout the period, defendant Allen Rowland, and later defendant Frank Lazaran, Rowland's successor as CEO, continued to tell investors that Winn-Dixie was following through on its strategic marketing plan. As evidence of its success and financial health, Winn-Dixie declared cash dividends throughout the period.

In June 2003, Rowland stepped down as CEO and received $7.7 million in severance pay, supposedly for improving store operations and enhancing the company's financial condition. When Lazaran replaced him, unbeknownst to the investing public, Lazaran allegedly ordered his senior management to conduct a 'comprehensive review' of Winn-Dixie's 'entire business model.' Even while this plan to restructure the company's business model was underway, Winn-Dixie and Lazaran continued to tell the public that the company was successfully executing its sales and marketing plan, with declared dividends to prove it. WD stock price rose throughout the period on this encouraging news.

On January 30, 2004, before the opening of trading, Winn-Dixie and Lazaran stunned the public with disastrous financial results for the company's second fiscal quarter ended January 7, 2004. WD sales were down over a quarter of a billion dollars from the prior year period. The company had sustained a loss of $79.5 million, or $0.57 per share. The company also announced that it would take a 'series of major actions' to change the way the company does business, including, brand positioning for its Winn-Dixie brand, $100 million in expense reduction by July 1, 2004, in-depth analysis of the company's core markets, market share, and competitive positioning, an 'image makeover program,' and an initiative to 'reengineer' organizational effectiveness and accountability. In addition, the company announced that it would recognize a $36.4 million charge to earnings for impairment to its long-lived assets, namely, its store locations, and would add $21.4 million to its reserves for self-insurance expense, which included additional reserves for workers' compensation claims. WD also cut its dividend indefinitely. The market reacted swiftly to the news-- Winn-Dixie's stock plunged from $9.09 to $6.56 per share on volume of 24.6 million shares.


At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints.

Other Stocks Cases of Interest

A class action has been filed against International Business Machines Corporation (IBM) (NYSE:IBM), certain of its officers and directors by stockholders who purchased the company's common stock between April 05, 2005 and April 15, 2005. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.
 
A class action has been filed against OfficeMax, Inc. (NYSE:OMX), certain of its officers and directors by stockholders who purchased the company's common stock between January 22, 2004 and January 11, 2005. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.
 
A class action has been filed against Emerson Radio Corporation (AMEX: MSN) and certain of its officers and directors by stockholders who purchased the company's common stock between January 29 and August 12, 2003.
 
A class action has been filed against Home Solutions of America, Inc. (HOM), certain of its officers and directors by stockholders who purchased the company's common stock between April 11, 2006 and June 6, 2006. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.
 
Several class actions have been filed against the officers and directors of biotechnology company Organogenesis, Inc. (formerly AMEX: ORG) by stockholders who purchased the company's common stock between November 15, 1999, and January 30, 2002. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.
 
A class action has been filed against Atherogenics, Inc. (NASDAQ:AGIX), a GA based research pharmaceutical company and certain of its officers and directors by stockholders who purchased the company's common stock between September 28, 2004 and December 31, 2004. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.
 
Become a LawCash Member - FREE!
'Find Money' E-Book
Weekly Email Alerts




privacy policy
YouNewz Beta
IT'S FREE

Report

Report Newz and easily upload your own newzworthy photos from your cell phone or computer to the web.

Share

Quickly share your photos with family, friends, co-workers, or the world with your own Newzpaper.

Read

Instantly find Newz and photos from other YouNewzers and read other YouNewzers Newzpapers.
 
Class Action Lawsuit Center || Product Recall Center || Consumer Complaint Center || About LawCash Link Exchange
Privacy Policy || Legal Policies || Terms & Conditions || Website Advertising Policy || Site Map || Top Lawsuits
LawCash® is a service of nola3, llc
© 2000 - 2008 Copyright. All rights reserved nola3, llc.

[ Home ]
LawCash
login
Justice is a click away.